NCT00230386View on ClinicalTrials.gov

Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2003

Conditions
Prostatic Neoplasms
Interventions
DEVICE

MRI

Trial Locations (1)

M5G 2M9

University Health Network Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00230386 - Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma | Biotech Hunter | Biotech Hunter